Niagen Financial Statements From 2010 to 2026

Niagen Bioscience Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 82.4 M 78.5 M 38.5 M Slightly volatile Total Current Liabilities 21.7 M 20.6 M 12 M Slightly volatile Total Stockholder Equity 55.7 M 53 M 23.1 M Slightly volatile Accounts Payable 5.8 M 9.8 M 6.4 M Slightly volatile Cash 53.7 M 51.2 M 20.1 M Slightly volatile Cash And Short Term Investments 53.7 M 51.2 M 20.1 M Slightly volatile Common Stock Shares Outstanding 96.3 M 91.7 M 52.9 M Slightly volatile Liabilities And Stockholders Equity 82.4 M 78.5 M 38.5 M Slightly volatile Other Stockholder Equity 275.2 M 262.1 M 127.4 M Slightly volatile Total Liabilities 13.1 M 25.5 M 14.6 M Slightly volatile Total Current Assets 77.4 M 73.7 M 34.1 M Slightly volatile Common Stock 66.9 K 88.5 K 66.5 K Pretty Stable Short and Long Term Debt Total 1.9 M 3 M 2 M Slightly volatile Other Current Liabilities 9.4 M 9 M 4.5 M Slightly volatile Property Plant And Equipment Net 3.2 M 4 M 3.2 M Slightly volatile Current Deferred Revenue 737.8 K 702.6 K 328.6 K Slightly volatile Non Current Assets Total 4.4 M 4.8 M 4.4 M Slightly volatile Non Currrent Assets Other 454.5 K 423.2 K 461 K Slightly volatile Net Receivables 9.4 M 8.9 M 4.3 M Slightly volatile Non Current Liabilities Total 3.1 M 4.9 M 3.2 M Slightly volatile Inventory 7.9 M 10.6 M 8.2 M Slightly volatile Other Current Assets 3.2 M 3 M 1.4 M Slightly volatile Short Term Debt 1.2 M 1.1 M 580.7 K Slightly volatile Intangible Assets 686.3 K 412.9 K 653.3 K Slightly volatile Capital Lease Obligations 3 M 2.4 M 4.2 M Slightly volatile Net Invested Capital 37.1 M 53 M 33.8 M Slightly volatile Property Plant And Equipment Gross 8.4 M 8.3 M 11.1 M Slightly volatile Capital Stock 80.8 K 88.5 K 71.3 K Slightly volatile Net Working Capital 37.1 M 53.1 M 33.5 M Slightly volatile
Niagen Bioscience Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Other Operating Expenses 110.9 M 105.7 M 56.5 M Slightly volatile Total Operating Expenses 65 M 61.9 M 36.5 M Slightly volatile Income Tax Expense 260.8 K 274.5 K 196.5 K Slightly volatile Depreciation And Amortization 936.4 K 1.7 M 960.8 K Slightly volatile Interest Expense 60.1 K 63.2 K 165 K Very volatile Selling General Administrative 17.6 M 21.1 M 17.9 M Slightly volatile Selling And Marketing Expenses 35.6 M 33.9 M 15.2 M Slightly volatile Total Revenue 120.3 M 114.5 M 47.4 M Slightly volatile Gross Profit 74.4 M 70.8 M 27.2 M Slightly volatile Cost Of Revenue 45.9 M 43.7 M 20.2 M Slightly volatile Research Development 3.8 M 6.9 M 3.1 M Slightly volatile Reconciled Depreciation 1.3 M 1.3 M 1.6 M Slightly volatile Interest Income 657.4 K 1.3 M 222.6 K Slightly volatile
Niagen Bioscience Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 33 M 31.4 M 15.3 M Slightly volatile End Period Cash Flow 53.9 M 51.4 M 20.2 M Slightly volatile Stock Based Compensation 3.9 M 4.2 M 3.9 M Slightly volatile Depreciation 936.4 K 1.7 M 960.8 K Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 6.59 5.24 6.0434 Slightly volatile PTB Ratio 10.75 11.32 20.5 K Slightly volatile Days Sales Outstanding 47.42 32.74 43.1289 Pretty Stable Book Value Per Share 0.26 0.49 0.3442 Slightly volatile Average Payables 2.3 M 2.2 M 2.2 M Slightly volatile Stock Based Compensation To Revenue 0.0401 0.0422 0.1263 Slightly volatile Capex To Depreciation 0.12 0.13 0.879 Slightly volatile PB Ratio 10.75 11.32 20.5 K Slightly volatile EV To Sales 6.23 4.75 5.6828 Slightly volatile Inventory Turnover 2.72 4.76 2.4839 Pretty Stable Days Of Inventory On Hand 135 79.44 169 Pretty Stable Payables Turnover 4.02 5.13 3.2602 Very volatile Sales General And Administrative To Revenue 0.2 0.21 0.5215 Slightly volatile Average Inventory 7.6 M 7.2 M 6.7 M Slightly volatile Research And Ddevelopement To Revenue 0.0648 0.0544 0.0665 Slightly volatile Capex To Revenue 0.0018 0.0019 0.0258 Slightly volatile Cash Per Share 0.49 0.47 0.2949 Slightly volatile Days Payables Outstanding 102 73.68 132 Pretty Stable Intangibles To Total Assets 0.0057 0.006 0.0241 Slightly volatile Current Ratio 1.94 3.21 2.4947 Slightly volatile Tangible Book Value Per Share 0.51 0.48 0.3474 Slightly volatile Receivables Turnover 8.59 11.54 10.7938 Pretty Stable Graham Number 0.88 0.99 1.0827 Slightly volatile Shareholders Equity Per Share 0.26 0.49 0.3442 Slightly volatile Debt To Equity 0.0628 0.0661 0.1717 Pretty Stable Capex Per Share 0.0021 0.0022 0.0137 Slightly volatile Average Receivables 3.9 M 3.7 M 3.6 M Slightly volatile Revenue Per Share 0.54 1.05 0.6974 Slightly volatile Interest Debt Per Share 0.0314 0.0279 0.041 Very volatile Debt To Assets 0.0535 0.0349 0.0683 Pretty Stable Operating Cycle 169 105 211 Slightly volatile Price Book Value Ratio 10.75 11.32 20.5 K Slightly volatile Days Of Payables Outstanding 102 73.68 132 Pretty Stable Ebt Per Ebit 1.14 1.32 1.0569 Pretty Stable Company Equity Multiplier 2.39 1.7 2.1276 Slightly volatile Long Term Debt To Capitalization 0.29 0.35 0.3632 Pretty Stable Total Debt To Capitalization 0.0594 0.0625 0.1173 Pretty Stable Debt Equity Ratio 0.0628 0.0661 0.1717 Pretty Stable Quick Ratio 2.89 2.75 1.8879 Slightly volatile Net Income Per E B T 0.97 1.11 0.9804 Pretty Stable Cash Ratio 2.34 2.23 1.4433 Slightly volatile Cash Conversion Cycle 38.09 40.09 77.8584 Slightly volatile Days Of Inventory Outstanding 135 79.44 169 Pretty Stable Days Of Sales Outstanding 47.42 32.74 43.1289 Pretty Stable Free Cash Flow Operating Cash Flow Ratio 1.24 1.13 1.1171 Pretty Stable Price To Book Ratio 10.75 11.32 20.5 K Slightly volatile Fixed Asset Turnover 27.29 25.99 13.37 Slightly volatile Debt Ratio 0.0535 0.0349 0.0683 Pretty Stable Price Sales Ratio 6.59 5.24 6.0434 Slightly volatile Asset Turnover 0.95 1.31 1.1595 Pretty Stable Gross Profit Margin 0.36 0.56 0.4612 Slightly volatile Price Fair Value 10.75 11.32 20.5 K Slightly volatile
Niagen Bioscience Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 428.6 M 408.2 M 186 M Slightly volatile Enterprise Value 389.1 M 370.6 M 169.9 M Slightly volatile

Niagen Fundamental Market Drivers

About Niagen Bioscience Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Niagen Bioscience is a strong investment it is important to analyze Niagen Bioscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Niagen Bioscience's future performance. For an informed investment choice regarding Niagen Stock, refer to the following important reports:

How To Invest In Niagen Details

Is Niagen Stock a good investment? Details

What is Niagen Bioscience's Net Worth? Details

Largest Life Sciences Tools & Services Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details